* Apyx Medical Corp APYX.OQ reported a quarterly adjusted
loss
of 28 cents per share for the quarter ended in December, lower
than the same quarter last year, when the company reported EPS
of -17 cents. The mean expectation of five analysts for the
quarter was for a loss of 18 cents per share. Wall Street
expected results to range from -23 cents to -11 cents per share.
* Revenue rose 16.3% to $14.66 million from a year ago;
analysts
expected $14.85 million.
* Apyx Medical Corp's reported EPS for the quarter was a
loss
of 28 cents.
* The company reported a quarterly loss of $9.61 million.
* Apyx Medical Corp shares had fallen by 29.4% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 8.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Apyx Medical Corp
is $3.50
This summary was machine generated from LSEG data March 21 at
01:30 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.18 -0.28 Missed
Sep. 30 2023 -0.11 -0.13 Missed
Jun. 30 2023 -0.07 -0.11 Missed
Mar. 31 2023 -0.13 -0.10 Beat